Promoted Companies
SORT BY:
NovaBay Pharmaceuticals, Inc. (NBY)
| Total paid for Promotions this month: | $0 | ||
| E-mails this Month: | 3 | ||
| Estimated Volume Generated: | $0 | ||
| Research Report on NBY: | Click to see | ||
| * The information presented is based on information for Sep , 2015 | |||
NovaBay Pharmaceuticals (NBY) Business Momentum Sep 10, 2015 07:28
NovaBay Pharmaceuticals (NBY) Business Momentum
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
NovaBay Pharmaceuticals, Inc. (NBY)
NBY‘s President and CEO Ron Najafi, Ph.D., will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the St. Regis
...read more
| Promoter: | Crweselect.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | Unknown compensation | UNKNOWN |
| Max Profit: 0.23 % | Gain at close: Pending |
NovaBay Pharmaceuticals (NBY) Business Momentum Sep 10, 2015 06:48
NovaBay Pharmaceuticals (NBY) Business Momentum
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
NovaBay Pharmaceuticals, Inc. (NBY)
NBY‘s President and CEO Ron Najafi, Ph.D., will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the St. Regis
...read more
| Promoter: | Crwefinance.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | Unknown compensation | UNKNOWN |
| Max Profit: 0.23 % | Gain at close: Pending |
NovaBay Pharmaceuticals (NBY) Business Momentum Sep 10, 2015 06:47
NovaBay Pharmaceuticals (NBY) Business Momentum
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
NovaBay Pharmaceuticals, Inc. (NBY)
NBY‘s President and CEO Ron Najafi, Ph.D., will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference is being held at the St. Regis
...read more
| Promoter: | Double in stocks | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | Unknown compensation | UNKNOWN |
| Max Profit: 0.23 % | Gain at close: Pending |
NBY reports 161 percent increase in Q1 2015 product sales May 27, 2015 19:06
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY) is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX™
...read more
| Promoter: | Buzz Stocks | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | No compensation | UNKNOWN |
| Max Profit: 4.42 % | Gain at close: 2.63 % |
NBY reports 161 percent increase in Q1 2015 product sales May 27, 2015 19:05
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY) is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX™
...read more
| Promoter: | PST Alerts | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | No compensation | UNKNOWN |
| Max Profit: 4.42 % | Gain at close: 2.63 % |
PennyStockProphet - NBY - New Alert: Pharma Pick Could Rally On... May 27, 2015 17:56
PSP Free Members,
I’ve discovered a new pick for members that I believe has the potential to stage a major run in the days ahead on HUGE news.
This relatively undiscovered pharma-pick is currently trading at just .75 per share; and is already on the upswing due to a strong increase in revenue through the first quarter of 2015.
The company reported a substantial 161 Percent
...read more
| Promoter: | Penny Stock Prophet | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| NBY | No compensation | UNKNOWN |
| Max Profit: 4.42 % | Gain at close: 2.63 % |
NovaBay Pharmaceuticals Mid-Year Clinical Update: Clinical Results... Jun 11, 2013 14:46
NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY)
NBY Research Links:
- News and Stock Info
Company Website
- NBY Website
Contact Us
RedChip Companies, Inc. 500 Winderley Place Ste 100 Maitland, FL 32751 Phone (800) RED-CHIP (800) 733-2447 www.redchip.com info@redchip.com
To unsubscribe, simply click here and enter the email address which received this message.
NovaBay Pharmaceuticals Mid-Year
...read more
| Promoter: | RedChip Companies, Inc. | Paying Party: | No Third Party |
NBY - Big Upside for Biotech in Late-Stage Trials Jun 06, 2013 12:53
NovaBay Pharmaceuticals, Inc.
(NYSE MKT: NBY)
June 3, 2013 Target Price: $5.00 Recent Price: $1.27
MARKET DATA
Fiscal Year
December 31
Industry
Biotechnology
Market Cap
$47.4M
Price/Earnings (ttm)
N/A
Price/Book (mrq)
4.6x
Price/Sales (ttm)
6.8x
EBITDA (ttm)
($9.0M)
ROE (ttm)
N/A
Institutional Ownership
9.5%
Shares Outstanding
37.3M
Float
30.9M
Avg
...read more
| Promoter: | RedChip Companies, Inc. | Paying Party: | No Third Party |